The Evidence Speaks (October 2018)
The twenty-third instalment of "The Evidence Speaks" Series includes the some of the latest research from CHÉOS Scientists on everything from post-operative protocols to resilience.
Read MoreSeptember 10, 2018
The Evidence Speaks Series is a recurring feature highlighting the latest in CHÉOS research. This series features summaries of select publications and is designed to keep the media and the research community up-to-date with CHÉOS’ current research results in the health outcomes field. To ensure this research is quick and easy to share, we are now providing social cards that you are free to save and use as you see fit.
The twenty-third instalment of "The Evidence Speaks" Series includes the some of the latest research from CHÉOS Scientists on everything from post-operative protocols to resilience.
Read More
The twenty-second installment of our “The Evidence Speaks” series, highlight the latest research from CHÉOS' Scientists and staff
Read More
This twenty-first installment of our "The Evidence Speaks" series highlights the latest CHÉOS research in cardiovascular health, preferences in preventative rheumatoid arthritis treatment, and adolescent obesity
Read More
The twentieth installment in our series, “The Evidence Speaks,” highlighting the latest in CHÉOS research.
Read More
The nineteenth installment in our series, “The Evidence Speaks,” highlighting the latest in CHÉOS research.
Read More
The Control of Hypertension in Pregnancy Study (CHIPS) Group, which includes CHÉOS Scientist Dr. Joel Singer and statistician Dr. Terry Lee, has published multiple research papers over the past decade
Read More